Advancements in Ophthalmology by Verana Health
At the recent meeting of the American Academy of Ophthalmology, Verana Health showcased its new suite of data and software enhancements dedicated to advancing ophthalmic research and improving patient care. With real-world insights drawn from over 85 million de-identified patients, these enhancements promise to revolutionize treatment options and optimize clinical practices.
Introduction of Cutting-Edge Data Solutions
Verana Health is committed to leveraging real-world data (RWD) that can drive significant improvements in the field of ophthalmology. The company’s innovations, unveiled during a major industry event, underscore its position as a leader in digital health and patient outcomes.
Integration Enhancements
One major enhancement is the integration of Site Explorer with Verana Trial Connect. These tools are designed to streamline the process for sponsors and clinical research organizations, enabling quicker site selections based on robust data analytics. This integration aims to facilitate better communication and decision-making among clinical trial stakeholders.
New Insights from Qdata Modules
Additionally, the introduction of new variables within the Ophthalmology Qdata collection highlights Verana’s commitment to thorough clinical insights. By including corneal staining and diplopia as key variables, researchers can more effectively study conditions that impact patient care and treatment strategies.
Enhancements to MIPS Advisory Services
Verana Health has also expanded its MIPS Advisory Services to support ophthalmology practices in maximizing their incentive payments while minimizing compliance burdens. These advisory services help practitioners navigate the complexities of MIPS reporting requirements, ensuring they remain compliant with evolving regulatory standards.
Exciting Announcements at the Upcoming Annual Meeting
The upcoming annual meeting of the American Academy of Ophthalmology is set to feature in-depth presentations from Verana Health. Attendees will gain valuable insights into how the company’s solutions can assist ophthalmologists in their practices. Notable topics include:
- Comprehensive overviews of MIPS Advisory Services tailored for health professionals.
- Collaborative research from Verana Health and Stanford University focusing on natural language processing to identify patients with complex conditions like thyroid eye disease.
- A presentation on optimizing MIPS through participation in the IRIS Registry to enhance time efficiency for clinicians.
About Verana Health
Verana Health is at the forefront of using artificial intelligence and physician input to unlock the potential of real-world data, particularly in the fields of ophthalmology, urology, and neurology. By providing critical insights that improve patient care and facilitate new therapy developments, Verana Health empowers clinicians and life sciences companies alike.
Frequently Asked Questions
What kind of data does Verana Health utilize?
Verana Health uses real-world data from a vast dataset of over 85 million de-identified patients to inform their research and patient care strategies.
How does the integration of Site Explorer and Verana Trial Connect benefit clinical research?
This integration allows for more efficient site selection and improves communication between clinical trial stakeholders, facilitating quicker patient enrollment.
What advancements have been made to MIPS Advisory Services?
Verana Health’s MIPS Advisory Services have expanded to provide coaching options to help ophthalmology practices maximize their incentive payments while ensuring compliance with reporting requirements.
What new insights are available from the Qdata collection?
The Qdata collection now includes new variables such as corneal staining and diplopia, which help provide a more comprehensive understanding of disease progression and treatment effectiveness.
Where can I learn more about Verana Health's offerings?
For more details, you can visit Verana Health's official website or stop by their booth at the upcoming annual meeting.
